ARCHIVES

MSKCC hopes to raise $1 billion in five-year campaign.

This article is from The Cancer Letter archive.

Vol. 29 No. 41 | November 7, 2003

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System

January 4, 2013

In Brief: White House Finally Okays Marks To Panel; NCAB Seeks More Data In RFP Announcements

July 2, 1976

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

Panel to Hear Innovation Reports

August 26, 1988